Accelerating Cross-Sector Integration in Pharma and Nutraceuticals
From the “AI Pilot Graveyard” to Enterprise- Grade Impact
Cloud-Native Drug Discovery
Early-Phase Oncology Trials Shaping the Future of Cancer Research
Controlling Polysorbate Degradation
EDITORIAL SECTION
-
STRATEGY
Smarter Pharma
Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solution
-
CLINICAL TRIALS
Why Clinical Trials Need Digital Endpoints
According Citeline the average success rate for bringing a Phase candidate to market has dropped to an alltime low of just
-
MANUFACTURING
Ensuring Quality and Compliance in Biopharma
Ensuring quality and regulatory compliance in the biopharmaceutical industry is critical to safeguarding product safety and efficacy
-
Information Technology
The Cost of Bad Data
Modern pharmaceutical research generates an unprecedented volume of information Data from genomic sequencing
-
Biopharma
Reimagining Global Biomanufacturing Capacity with Continuous and Modular Systems
Biotechnology is fueling the ongoing expansion of the global market for a broad array of goods
-
EXPERT Talk
Compliance to Competitive Advantage in Pharma Supply
Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser
Advisory Board
.webp)
KNOWLEDGE BANK
-
Articles
What Is Clinical Pharmacology and Its Importance for Drug Development and Patient Care
Clinical pharmacology is the critical interface between laboratory science and the education of patients Put simply it is the science that researches the interaction of drugs with the human body and the reaction of the latter to drugs People pose the question what is clinical pharmacology The solution can be found in its multidisciplinary character of the matter combining pharmacology medicine ge...
Key Stages in Pharmaceutical Formulation Development: A Complete Guide
One of the most significant operations in the field of drug study is pharmaceutical formulation development to ensure that the medications are distributed to the patients without harm and in the most appropriate manner This is a science that involves the transformation of an active pharmaceutical ingredient API into a solid efficient and convenient dosage form To researchers manufacturers and regu...
The Impact of Digital Health Technologies on Patient Outcomes
It is also noteworthy that the structure of the healthcare system has shifted rather dynamically in the past few years primarily because of the integration of digital health solutions Such developments
Antibody-Drug Conjugates (ADCs): Driving the Next Generation of Precision Oncology
An antibodydrug conjugate is a targeted cancer therapy that links a potent cytotoxic drug to a monoclonal antibody through a chemical linker so the antibody delivers the payload directly to tumour cells expressing a chosen antigen The design widens the therapeutic window it concentrates cytotoxic activity where the target is expressed and limits the systemic exposure that constrains conventional c...
Pharmaceutical Quality Management in Europe: GMP Systems, Quality Control and Manufacturing Standards
A tablet that works in a lab means little if the next batch is slightly different Pharmaceutical quality management exists to make sure every pack in every pharmacy matches the one that was tested and approved In Europe that promise is backed by one of the most mature regulatory frameworks in the world Whether you run a small contract manufacturer in Ireland or a large sterile plant in Germany EU...
Pharmaceutical Market Access and Reimbursement Strategies in Europe
Getting EMA approval is a milestone but it isnt a launch In Europe a medicine can be authorized in every member state and still not reach a single patient until each country agrees on its price and who pays for it That gap between approval and access is where pharmaceutical market access is won or lost
-
Techno Trends
Alume Biosciences Secures FDA Breakthrough Therapy Designation for Bevonescein
Alume Biosciences has received Breakthrough Therapy Designation BTD from the US Food and Drug Administration FDA for bevonescein an investigational fluorescent drug being developed to support realtime nerve visualisation during head and neck surgery in adults Bevonescein is an intravenous fluorescent peptidedye conjugate that binds to nerve tissue
-
Projects
SK pharmteco Plans More Than US$200 Million Investment in Small Molecule and Peptide Manufacturing
SK pharmteco is planning a fiveyear investment of more than US million to expand and modernise its pharmaceutical development and manufacturing operations in the United States The programme will strengthen capabilities for small molecules and peptides while supporting a more
-
Research Insights
A drug repurposing screen reveals dopamine signaling as a candidate therapeutic pathway for PIGA-CDG
PIGACDG is a congenital disorder of glycosylation caused by pathogenic partial lossoffunction variants in the PIGA gene PIGA encodes an enzyme responsible for the catalytic transfer of Nacetylglucosamine
-
whitepaper
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys
TOP ARTICLES
-
1
Key Stages in Pharmaceutical Formulation Development: A Complete Guide
Kate Williamson
This article provides a guide to pharmaceutical formulation development, including all the steps that need to be undertaken, starting with pre-formulation studies to clinical trials and regulatory app...
-
2
The Impact of Digital Health Technologies on Patient Outcomes
Kate Williamson
Telemedicine and telecare, m-health, wearable devices, electronic health records, and big data analytics are the digital health technologies that are becoming the agents of change in the health care s...
-
3
Antibody-Drug Conjugates (ADCs): Driving the Next Generation of Precision Oncology
Lakshmi
Antibody-drug conjugates have moved from salvage therapy to the strategic centre of precision oncology. With more than twenty ADCs approved worldwide and hundreds in development, the decisive question...
-
4
Pharmaceutical Quality Management in Europe: GMP Systems, Quality Control and Manufacturing Standards
Sarah Richards
European pharmaceutical quality rests on EU GMP, a risk-based quality system and rigorous quality control. This article explains how EudraLex Volume 4, Qualified Persons, data integrity and Annex 1 sh...
-
5
Pharmaceutical Market Access and Reimbursement Strategies in Europe
Kate Williamson
Securing patient access in Europe means navigating national pricing, reimbursement, and the new EU Health Technology Assessment Regulation. This article explains how pharmaceutical market access works...
press releases Read more...
Biocodex Invests €15 Million in a New Industrial Platform for Live Biotherapeutic Products
Biocodex an independent French pharmaceutical company announces a million investment to develop an industrial platform in Beauvais France dedicated to Live Biotherapeutic Products LBPs derived from the microbiome Building on more than years of expertise in living microorganisms microbiota fermenta...
Boehringer Ingelheim and SBP Group enter partnership to advance next-generation cancer therapies
Boehringer Ingelheim headquartered in Germany and Sino Biopharmaceutical Limited HK together with its subsidiaries SBP Group today announced a strategic multiprogram option and license agreement to advance potential nextgeneration cancer treatments based on antibodydrug conjugate ADC and Tcell engag...
Nxera Pharma Enters into Global License Agreement with AbbVie for NXE0033744, a Novel EP4 Receptor Agonist for Inflammatory Bowel Disease
Nxera Pharma Co Ltd announces that its subsidiary Nxera Pharma UK Ltd has entered into an exclusive global license agreement the Agreement with AbbVie Inc AbbVie for Nxeras EP agonist program including NXE a novel small molecule EP receptor agonist discovered
Oryzon announces authorization in Spain of VIVALDI, a collaborative clinical study with CETLAM to evaluate iadademstat in combination with standard-of-care therapy in high-risk newly-diagnosed AML subpopulations
Oryzon Genomics SA a clinicalstage biopharmaceutical company and global leader in epigenetics today announced that VIVALDI a Phase Ib pilot study sponsored by CETLAM Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplsicas has been authorized in Spain
Events Read more...
09 - 11
Nov 202611th Microbiome Movement USA Summit
The Colonnade Hotel, Boston, M...
10 - 11
Nov 2026Extractables & Leachables Europe
Parkhotel Schӧnbrunn, Vienna,...
10 - 10
Nov 2026Women in AI
Real Chemistry, 2nd Floor, Lon...
11 - 13
Nov 2026Frontiers in Cancer Science 2026
One Farrer Hotel,1 Farrer Park...
11 - 12
Nov 2026Medical Device Project and Portfolio Management
Chicago, IL, USA
16 - 17
Nov 2026Analytics for Smarter Decisions in Pharma
London, UK
24 - 25
Nov 2026BioPharma Deals - The Survival Series
Munich, Germany
24 - 27
Nov 2026Pharmtech & Ingredients 2026
Crocus Expo, Pavilion 2, Mosco...
LATEST NEWS Read more...
Portal Innovations and Altitude Lab Partner to Strengthen Utah’s Life Sciences Startup Ecosystem
Portal Innovations a venture development platform supporting earlystage life sciences companies today announced a strategic partnership with Altitude Lab to strengthen the resources available to life sciences entrepreneurs in Salt Lake City Through the partnership Altitude Lab will relocate its acce...
MRM Health and Biocodex establish strategic partnership to strengthen future commercial supply capabilities for CORAL®-based medicines
MRM Health a clinicalstage biotech developing microbiomebased therapies for immunemediated diseases and Biocodex an independent French pharmaceutical company with more than years of experience in the microbiome field today announced the launch of a strategic partnership to establish specialized man...
Breakthrough Therapy Designation granted by the FDA for daridorexant in pediatric insomnia disorder
Idorsia Ltd announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation to daridorexant for the treatment of insomnia disorder in patients to
Evestia Clinical Acquires Emtex Life Science to Further Enhance its Global Full-Service Clinical Research Capabilities
Evestia Clinical a leading independent global specialist Contract Research Organization CRO today announced the acquisition of Emtex Life Science Emtex a specialist regulatory medical writing company headquartered in Belgium The acquisition strengthens Evestia
UroGen Announces First Patient Dosed in Phase 1 Trial of UGN-501, an Investigational Next-Generation Oncolytic Virus for Non-Muscle Invasive Bladder Cancer
UroGen Pharma Ltd a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers today announced that the first patient was dosed with UGN a nextgeneration investigational oncolytic virus The Phase trial will evaluate the safety tolera...
Graviton BioScience and CinRx Pharma Form CinRock Pharma to Advance ROCK2-Targeted Therapies for Cardiovascular Disease
Graviton BioScience Corporation Graviton and CinRx Pharma CinRx today announced the formation of CinRock Pharma CinRock a jointly governed biopharmaceutical company established to accelerate the development of novel ROCKtargeted therapies for patients with cardiovascular diseases
